Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies.
| Autor: | Genovese, Mark C.1 genovese@stanford.edu, Durez, Patrick2, Fleischmann, Roy3, Yoshiya Tanaka4, Furst, Daniel5, Hisashi Yamanaka6, Korneva, Elena7, Vasyutin, Igor7, Tsutomu Takeuchi8 |
|---|---|
| Zdroj: | European Journal of Rheumatology. Jul2021, Vol. 8 Issue 3, p120-129. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|